Nate Diaz, Jon Jones, Brock Lesnar Reach Settlements with NAC Ahead of Thursday Hearings
By: Jordan Breen Dec 12, 2016
Thursday, we should get clarity on the immediate futures on three
of the sport's biggest stars.
The Nevada Athletic Commission announced the schedule for its
forthcoming meeting on Dec. 15 and the docket features hearings for
Diaz, Jon Jones and
Lesnar, all of whom will have discussion and potential approval
of their “proposed adjudication agreements” regarding outstanding
Diaz's hearing is related to his part in the now-infamous pre-UFC
202 press conference, where he and opponent Conor
McGregor ended up throwing water bottles and cans, while Jones
and Lesnar both face discipline for failed drug tests in July
before UFC 200. All three men have been granted several
continuances in their respective cases before reaching their
reported agreements with the commission.
Both Jones and Lesnar tested positive for anti-estrogenic agent
hydroxyclomiphene prior to UFC 200, while the former light
heavyweight king Jones also popped for Letrozole metabolite, an
While the details of Diaz and Lesnar's settlements with the
Commission are unknown, MMAFighting was
first to break the news on Jones' deal with the NAC last week,
reporting that “Bones” has agreed to a one-year suspension, to run
concurrently with his punishment handed down by the United States
Anti-Doping Agency. The one-year ban is retroactive to July 6, when
the results of Jones' failed June 16 test were first revealed, and
will expire July 6, 2017.
In his USADA hearing, Jones blamed his positive test on a
sexual-enhancement pill, which USADA independently verified had
been tainted with the banned substances in question. However, the
agency felt Jones had not done his due diligence before taking the
pill, leading to the 12-month suspension.
Lesnar's legal team has publicly stated it has independently tested
both a foot cream and an eye medication as potential causes for the
former UFC heavyweight champ's positive test.